Zepp Health Corporation Sponsored ADR ZEPP
4.14
0.02
0.49%
as of 25 Sep
- Market cap
- $34.9M
- P/E
- 0.0×
Follow ZEPP
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (21.23%) | (18.76%) | (17.15%) | (24.35%) |
+8 more TTM periods Free account |
|
| (7.86%) | (7.60%) | (7.33%) | (11.23%) | ||
ROIC |
(10.25%) | (8.18%) | (8.43%) | (9.25%) | |
Return on Tangible Assets |
164.91% | 135.69% | (324.62%) | (208.31%) | |
Average Days of Receivables |
109.21 | 83.77 | 103.73 | 136.43 | |
Free Cash Flow per Share |
0.00 | 0.00 | (7.55) | 0.00 | |
Free Cash Flow |
— | — | (119.99) | — | |
Capital Expenditures |
— | — | 1.69 | — | |
Piotroski F-Score |
— | — | 1.00 | — | |
| Other line items | |||||
Cash ROIC |
0.00% | 0.00% | (27.49%) | 0.00% | |
Accounts Receivable Turnover |
3.51 | 4.61 | 3.72 | 3.52 | |
Accounts Payable Turnover |
1.94 | 2.79 | 2.42 | 2.14 | |
Inventory Turnover |
2.38 | 2.64 | 2.47 | 1.78 | |
Average Days of Payables |
189.43 | 128.98 | 184.59 | 261.65 | |
Days of Inventory on Hand |
134.43 | 136.82 | 166.28 | 218.34 | |
Tax Rate |
0.07 | 0.08 | 0.07 | 0.29 | |
Research and Development Expense of Revenue |
16.83% | 16.95% | 17.50% | 19.46% | |
Selling, General and Administrative Expense of Revenue |
34.34% | 31.90% | 32.10% | 32.41% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 8.95% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 3.04 | 0.00 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 4.55 | 0.00 | |
Capex/Depreciation |
— | — | 0.07 | — | |
Revenue per Share |
17.43 | 17.13 | 16.28 | 14.75 | |
Operating CF per Share |
0.00 | 0.00 | (7.65) | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.11 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | (0.01) | 0.00 | |
Net Profit Margin |
(15.78%) | (14.70%) | (15.48%) | (28.28%) |
Columns are period end dates